Professor Anne Lingford-Hughes has been Professor of Addiction Biology at Imperial College since 2009. She is also a Consultant Psychiatrist with a particular interest in pharmacological treatments of alcohol problems and comorbidity at Central North West London NHS Foundation Trust. Her research has focused on using neuroimaging and neuropharmacological challenges to characterize the neurobiology of addiction. In particular she has used positron emission tomography (PET) to characterize the dopamine, opioid and GABA-benzodiazepine receptor systems in alcoholism and opiate dependence. She is currently working on MRC funded studies, one with Cambridge and Manchester, on pharmacology of different vulnerabilities to relapse in alcohol, heroin and cocaine addiction. In another collaboration with Cambridge, she is exploring the neurobiology of gambling to compare this behavioural addiction with drug addiction.
If you are interested in finding out more about our studies into alcoholism and participating if you are abstinent and well, please email email@example.com for more information.
Prof Lingford-Hughes leads the MRC Addiction Research Clinical Training Programme (MARC) with Prof Colin Drummond, IOPPN, KCL and Prof Matt Hickman, University of Bristol. For events and opportunities associated with MARC see https://www.imperial.ac.uk/medicine/study/mrc-addiction-research-clinical-training/
Prof Lingford-Hughes is past Hon. General Secretary of the British Association for Psychopharmacology. She co-developed and wrote their guidelines about the pharmacological management of substance misuse and addiction and comorbidity with psychiatric disorders. She has also contributed to NICE guidance regarding pharmacotherapy of opiate detoxification and alcohol misuse and dependence.
She is currently Chair of the Academic Faculty of RCPsych.
She graduated in medicine from Oxford University, completed her PhD at Cambridge University, and trained in psychiatry at The Bethlem and Maudsley Hospitals and Institute of Psychiatry.
et al., Neural substrates of cue reactivity and craving in Gambling Disorder, Translational Psychiatry, ISSN:2158-3188
et al., 2016, BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment, Journal of Psychopharmacology, Vol:30, ISSN:0269-8811, Pages:717-748
et al., 2016, Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology, Journal of Psychopharmacology, Vol:30, ISSN:0269-8811, Pages:495-553
et al., 2016, Ethanol Reversal of Tolerance to the Respiratory Depressant Effects of Morphine, Neuropsychopharmacology, Vol:41, ISSN:0893-133X, Pages:762-773
Lingford-Hughes A, 2016, Substitution treatment in addiction: there is more than one way..., Addiction, Vol:111, ISSN:0965-2140, Pages:776-777